Surface Oncology, Inc. Free Cash Flow 2018-2023 | SURF
Surface Oncology, Inc. free cash flow from 2018 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Surface Oncology, Inc. Annual Free Cash Flow |
| 2022 |
-60.05 |
| 2021 |
-62.46 |
| 2020 |
29.95 |
| 2019 |
-61.68 |
| 2018 |
-15.24 |
| 2017 |
-14.40 |
| 2016 |
40.58 |
| Surface Oncology, Inc. Quarterly Free Cash Flow |
| 2023-06-30 |
-43.00 |
| 2023-03-31 |
-23.43 |
| 2022-12-31 |
-60.05 |
| 2022-09-30 |
-38.00 |
| 2022-06-30 |
-19.12 |
| 2022-03-31 |
-23.60 |
| 2021-12-31 |
-62.46 |
| 2021-09-30 |
-46.54 |
| 2021-06-30 |
-31.23 |
| 2021-03-31 |
-18.96 |
| 2020-12-31 |
29.95 |
| 2020-09-30 |
-42.33 |
| 2020-06-30 |
-32.07 |
| 2020-03-31 |
-15.60 |
| 2019-12-31 |
-61.68 |
| 2019-09-30 |
-48.21 |
| 2019-06-30 |
-33.55 |
| 2019-03-31 |
-19.18 |
| 2018-12-31 |
-15.24 |
| 2018-09-30 |
-0.18 |
| 2018-06-30 |
12.26 |
| 2018-03-31 |
30.53 |
| 2017-12-31 |
-14.40 |
| 2017-09-30 |
0.65 |
| 2017-06-30 |
10.17 |
| 2017-03-31 |
-4.58 |
